GAST and gastrin-producing neuroendocrine tumor: GEP-NETs that secrete the gastric peptide hormone gastrin (i.e., gastrinoma) comprise the most clinically aggressive of MEN1 cases, with 60% of patients presenting with lymph node metastases upon diagnosis (7).